title: Steroids in pediatric eosinophilic esophagitis.
abstract: Swallowed fluticasone and oral viscous budesonide are effective first-line therapies for eosinophilic esophagitis in children. Side effects are minimal without evidence of Cushing syndrome, as seen in treatment with systemic corticosteroids. New studies on alternative delivery systems and different corticosteroids (eg, ciclesonide) are encouraging. As knowledge of corticosteroids in eosinophilic esophagitis expands, newer questions continue to arise concerning dose, delivery, and choice of corticosteroids; long-term adverse effects; and maintenance therapies.
authors.affiliation: Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, 705 Riley Hospital Drive, ROC 4210, Indianapolis, IN 46202, USA.
authors.forename: Emily M
authors.initials: EM
authors.lastname: Contreras
authors.affiliation: Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, 705 Riley Hospital Drive, ROC 4210, Indianapolis, IN 46202, USA. Electronic address: sgupta@iu.edu.
authors.forename: Sandeep K
authors.initials: SK
authors.lastname: Gupta
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000465:Algorithms; D002648:Child; D057765:Eosinophilic Esophagitis / Q000188:drug therapy*; D006801:Humans; D060046:Maintenance Chemotherapy
chemical_list: D000305:Adrenal Cortex Hormones
keywords: Budesonide; Children; Ciclesonide; Eosinophilic esophagitis; Fluticasone; Steroids; Topical steroids